Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...

Vaccination against the Respiratory Syncytial Virus (RSV) will now cover babies up to ten months old in the autumn-winter ...

A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...

Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our ...

Major study shows that adults with respiratory syncytial virus-associated acute respiratory infection face a 2.7-fold higher ...

After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

Researchers from the Wesfarmers Center of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, ...

Adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) are likely to be at a 2.7-fold higher risk of death within one year, warned a study. Highly contagious ...

Lassen and colleagues observed higher incidence of CV events during the acute phase of RSV infection compared with the control period, and reported the following incidence rate ratios (IRR): The ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods ...